Todd Subritzky Doctorate

Total Page:16

File Type:pdf, Size:1020Kb

Todd Subritzky Doctorate Health Faculty National Drug Research Institute A Multi-source Investigation of Issues Arising from the Implementation and Evolution of a Commercial, Non-medical Cannabis Market in Colorado Todd Subritzky This Thesis is Presented for the Degree of Doctor of Philosophy of Curtin University November, 2019 1 Declaration To the best of my knowledge and belief, this thesis contains no material previously published by any other person except where due acknowledgment has been made. This thesis contains no material which has been accepted for the award of any other degree or diploma in any university. Human Ethics The research presented and reported in this thesis was conducted in accordance with the National Health and Medical Research Council National Statement on Ethical Conduct in Human Research (2007) – updated March 2014. The proposed research study received human research ethics approval from the Curtin University Human Research Ethics Committee (EC00262), Approval Number # HRE2016-0230 Signature: Todd Subritzky Date: 20/11/19 2 Abstract In November 2012, voters in Colorado used a direct democracy initiative to legalise a commercial cannabis market for pleasure - thereby ending 95 years of prohibition in the State. When the first stores opened 13 months later, following a complex and intense pre-implementation period for regulators, Colorado became the first jurisdiction globally to implement a regulated, adult-use cannabis supply chain from seed-to-sale. It was reported as an historic occasion that presaged a grand social and economic experiment in drug legalisation. This thesis has the overall objective of examining issues arising from the implementation and evolution of the world’s first fully commercialised cannabis market in Colorado. It aims to provide early qualitative insights from the pre- implementation phase and the first five years post implementation. The research is conducted primarily from a harm reduction perspective that includes evidenced based recommendations founded on real-world experience. This is a multi-source investigation and a qualitative descriptive methodology is embraced to examine the corpus of data. This corpus includes hundreds of pages of government documents related to the pre-implementation phase, a sample of 969 mass and niche media articles (2014 – 2016), and interviews in the field with 32 key stakeholders in 2016 and 2017 including senior government officials, industry executives, and front-line public health representatives. Document analysis, thematic analysis, thick description, and both inductive and deductive coding techniques are used to analyse the data and report findings. A major finding of the thesis is that while regulators implemented a functioning system within tight deadlines that established a predictable funding mechanism and that the ‘sky had not fallen in’ immediately post-implementation, the scheme faced major challenges including the conflict with continued federal prohibition, a growing influence of the cannabis industry, and immature cannabis product testing regimes that limited the effectiveness of the regulation to provide a safe product for consumers. 3 Multiple recommendations relevant for other jurisdictions considering the legalisation of cannabis are presented in the final chapter of the thesis. Because it examines a first of its kind legal cannabis market, the study will be of interest to a wide variety of stakeholders including public health researchers, policy and lawmakers, drug policy reform advocates, and the general public both in the US and internationally. It may be of particular interest to regulators in countries such as New Zealand, who have a similar population to Colorado and will vote on legalising cannabis in 2020, Australia where ACT (like Colorado) has legalised small amounts of cannabis (although not a commercial market) in contradiction of federal law in late 2019, or other states in the US considering non-prohibition cannabis models. 4 Acknowledgements For the most part, the past years of this research project have been an enthralling and immensely satisfying period of my life. People often say that to complete a PhD there are two required conditions, namely, a topic that you are genuinely fascinated by and engaged supervisors. I was fortunate to have both elements. Indeed, I am privileged to have been afforded this opportunity, one that I hope to have honoured by seizing. I suppose, as a response to an impending mid-life crisis, doing a PhD is an altogether predictable activity. Perhaps, though, it is not for the feint hearted or thin skinned, you are going to be challenged from the outset, which was the point in my case. My journey would not have been possible without the assistance, guidance, wisdom, and support of a number of people. First, in general to the Coloradan people with their wonderful hospitality, but specifically to the interviewees who freely gave of their time and openly discussed the issues, thank you. The thesis has benefited greatly from your experience. Second, to my supervisors Professors Simon Lenton and Simone Pettigrew, both world class academics in their own rights but also quality human beings, as the Danish say, tusind tak (a thousand thank yous). Everything they have said has been for the purpose of improving the thesis and I have been extremely fortunate to have this level of guidance throughout. As one of the world’s foremost minds on cannabis policy, both as an academic and government advisor, the wisdom and knowledge of Professor Lenton in particular has been an invaluable asset and I am grateful for that. Third, to Dr David Baker you have been an inspiration and your friendship, support, and advice have been indispensable and very much appreciated – long may that continue. I wish you well in your new role at Liverpool University. Fourth, to Professor Beau Kilmer, thanks and acknowledgements for introductions to several study participants, which led to yet further introductions. This access to the highest levels of government in Colorado strengthened the thesis. Fifth, Jo Hawkins and Paul Jones at NDRI have consistently gone above and beyond to assist me. Sixth, many thanks to Dr Nyanda McBride, who as thesis chairperson has always responded promptly to my enquires. Finally, to my family, while it has been a wonderful and challenging journey for me, I suspect it has leaned towards the latter for you. To Mum, who always believed in me and provided a spring in the step when it was needed, thanks. My daughter Jade was the inspiration to be the best I could be, which I hope in turn will inspire her as she heads into a second decade and out into the wider cosmos. 5 Navigating this ‘hybrid thesis’ This is a hybrid thesis. Each results chapter consists of a research article with a structure typical in peer-reviewed journals. Throughout the course of the author’s PhD candidacy, eight papers related to the research topic were submitted for publication in high-quality international journals and a peer-reviewed book chapter. At time of writing, these papers had been cited over 140 times according to Google Scholar. Five of the papers are research articles and are included in the results section of this thesis. I have obtained permission from the copyright owners to use any of my own published work (e.g. journal articles) in which the copyright is held by another party (e.g. publisher, co-author). For reader convenience, each result chapter also includes a brief footnote that places the specific paper into the context of the overall thesis objectives. The three additional articles included two commentaries and an editorial. These are presented in Appendix F of the thesis as supporting material that emerged from the research program but were considered outside the scope of the thesis objectives. The thesis has been written in line with Curtin University Guidelines for a PhD ‘hybrid’ thesis (Curtin University, 2019), with a strong focus on presenting a coherent body of work and assisting the reader by eliminating unnecessary repetition. To improve readability and avoid repeating text, edits have been made where appropriate to the original journal articles (such cases are clearly indicated in the text). For example, references from all papers in the results section have been moved to the references section of the thesis. In addition, in three cases (chapters 7-9) the method sections of published papers have been edited out to avoid repeating material that was presented in Chapter 5. Furthermore, recommendations that emerged from the results have been moved from individual results chapters to the overall discussion of the thesis. This allowed for the thesis to be presented as an integrated body of knowledge despite differing from the traditional structure of a typeset thesis. 6 Chapters 1-5 set out the thesis objectives, outline the research context, and describe the research methodology in the usual manner. Chapters 6-10, which contain published and submitted research articles and a book chapter, constitute the results section of the thesis. Chapter 11 is presented in this thesis as a “Discussion” in the same way as a traditional thesis whereby the results chapters are synthesised and discussed alongside study limitations and future research directions. Supporting material is presented in the Appendices of the thesis. It is advised that the reader use the side navigation pane to navigate the thesis. Table 1 below contains information about publications in the thesis including full reference, publication status, journal impact factor, and number of times the paper had been cited by November 2019 according to Google Scholar. As the author of this PhD thesis, I hold the first authorship of all research papers. Thesis supervisors who contributed significantly to the research are listed as co-authors on the publications (see Appendix H for written statements of authorship). I have received permission from all copyright holders to reprint journal articles and other outputs in this thesis (see Appendix E for details).
Recommended publications
  • Effects of Combined THC and Heroin Vapor Inhalation
    Psychopharmacology https://doi.org/10.1007/s00213-021-05904-w ORIGINAL INVESTIGATION Efects of combined THC and heroin vapor inhalation in rats Arnold Gutierrez1,2 · Jacques D. Nguyen1,2 · Kevin M. Creehan1,2 · Mehrak Javadi‑Paydar1 · Yanabel Grant1,2 · Michael A. Tafe1,2 Received: 27 April 2021 / Accepted: 27 May 2021 © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 Abstract Rationale Opioids are efective medications, but they have several key limitations including the development of tolerance, establishment of dependence, diversion for non-medical use, and the development of addiction. Therefore, any drugs which act in an additive or synergistic fashion with opioids to address medical applications have the potential to reduce opioid- related harms. Objectives To determine if heroin and Δ9-tetrahydrocannabinol (THC) interact in an additive or independent manner to alter nociception, body temperature, and spontaneous locomotor activity when inhaled or injected. Methods Groups of female and male rats, implanted with radiotelemetry transmitters, were exposed to vapor generated from heroin (50 mg/mL in propylene glycol vehicle; PG), THC (50 mg/mL), or the combination for assessment of efects on temperature and activity. Thermal nociception was assessed with a warm water tail-withdrawal assay. Results Heroin inhalation increased temperature and activity whereas THC inhalation decreased temperature and activity in both female and male Sprague–Dawley rats. Efects of combined inhalation were in opposition, and additional experiments found the same outcome for the injection of heroin (0.5 mg/kg, s.c.) and THC (10 mg/kg, i.p.) alone and in combination.
    [Show full text]
  • Openvape: an Open-Source E-Cigarette Vapour Exposure Device for Rodents
    Research Article: Open Source Tools and Methods | Novel Tools and Methods OpenVape: an Open-Source E-Cigarette Vapour Exposure Device for Rodents https://doi.org/10.1523/ENEURO.0279-20.2020 Cite as: eNeuro 2020; 10.1523/ENEURO.0279-20.2020 Received: 27 June 2020 Revised: 30 July 2020 Accepted: 18 August 2020 This Early Release article has been peer-reviewed and accepted, but has not been through the composition and copyediting processes. The final version may differ slightly in style or formatting and will contain links to any extended data. Alerts: Sign up at www.eneuro.org/alerts to receive customized email alerts when the fully formatted version of this article is published. Copyright © 2020 Frie et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. 1 Manuscript Title Page Instructions 2 1. Manuscript Title (50 word maximum) 3 4 OpenVape: an Open-Source E-Cigarette Vapour Exposure Device for Rodents 5 2. Abbreviated Title (50 character maximum) 6 7 OpenVape: an Open-Source Vapour Exposure Device 8 3. List all Author Names and Affiliations in order as they would appear in the published article 9 10 Jude A. Frie – Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, 11 Ontario, Canada. 12 Jacob Underhill – Department of Biomedical Sciences, Ontario Veterinary College, University of 13 Guelph, Ontario, Canada. 14 Bin Zhao – Departments of Pharmacology and Toxicology, University of Toronto, Ontario, Canada 15 Giordano de Guglielmo – Department of Psychiatry, University of California, San Diego, San Diego, 16 California, USA.
    [Show full text]
  • How Adam Bierman Built Medmen Into an Influential Industry Player
    Creating a best-selling cannabis edible in a crowded market $12.95 VOL 4 • ISSUE 8 • September 2017 Crop storage+ strategies Vape industry overview Getting a grow NO off the ground APOLOGHow Adam Bierman built ¬ES MedMen into an influential industry player despite his blunt, controversial style 312.869.9070 IF YOU’RE NOT MESSAGING YOUR CUSTOMERS, THEN SOMEBODY ELSE IS! SMS is the best and most effective way to increase your daily store traffi c. Our clients say a blast brings in 10-50 incremental customers (per 1000 messaged). MESSAGING PAYS FOR ITSELF 10 TIMES OVER! A 420 sending number to increase Reliable delivery. No blocking. brand effectiveness. Excellent customer service. UP TO 240 CHARACTERS PER MESSAGE Need help building your opt in list? (50% more than others). More info to We got you covered. your customers means more sales. Great prices. Discounts for Picture messaging (MMS) available. higher volumes. No contracts or setup fees. 90% OF SMS ARE READ WITHIN 3 MINUTES OF RECEIPT. 4 20 YOU CAN’T AFFORD Thursday, April 20 NOT TO USE NORTHTEXT. Dispensary now SMS messaging expertise tailored specifi cally to the Dispensary market WWW.NORTHTEXT.COM/DISPENSARY | 312.869.9070 In business since 2007 Trim-8.375x10.875.qxp_Layout 1 1/20/17 10:22 AM Page 1 System 420™ Hybrid Greenhouses Larger Yields, Better Crops, Lower Costs PRODUCTION YIELDS With over 1 million square feet of Light deprivation, environmental controls, and benching systems Why Nexus? cannabis greenhouses constructed in provide the tools to optimize the 11 states, Nexus has developed unique expertise in designing grow system for high capacity integrated cannabis growing systems.
    [Show full text]
  • CAN2021 Abstracts
    CAN-ACN 2021 Submitted Abstracts ABOUT VISTA VISTA is a collaborative research program funded by the Canada First Research Excellence Fund (CFREF). VISTA builds on York University’s world- leading interdisciplinary expertise in biological and computer vision with over 80 academic, public, and for-profit partners. HIGHLIGHTS MISSION Our mission is to advance vision science through computational and biological research perspectives and to produce applications that generate positive economic, societal, health and technological impacts for Canada and the world. FUNDED TO DATE BECOME A VISTA AFFILIATE/PARTNER Program benefits: Become a member of an interdisciplinary research community across BECOME A VISTA TRAINEE the research areas of health, science, engineering, humanities, & arts Master's Scholarships Work with over 80 industry partners offering opportunities for research 2 year funding ($10,000/year), in addition collaboration and product development to standard York University funding Supervisor must be a VISTA Core member Join an international network pushing the boundaries of vision PhD Scholarships research in North America, Europe, and Asia 4 year funding ($10,000/year), in addition to standard York University funding Collaborate on VISTA-funded research projects Supervisor must be a VISTA Core member Postdoctoral Fellows Participate in VISTA-funded events 2 year funding ($55,000/year) Yearly Research and Networking allowances Travel Awards to support expenses for visiting scholars, students, and fellows to/from current VISTA partners CONTACT/FOLLOW US [email protected] @vistayorku Visit us: yorku.ca/vista Contents Parallel symposium 1: Neurovascular function in health and disease .......................................... 1 Parallel symposium 2: The hypothalamus and its hormones in health & disease......................
    [Show full text]
  • The “Green Gold Rush”
    ACKRELL CAPITAL U.S. CANNABIS INVESTMENT REPORT 2016 The “Green Gold Rush” Contents n Foreword I Executive Summary II Legislative Landscape; Legal Issues for Investor Consideration III Cannabis 101 IV U.S. Cannabis Market Estimates Overview V Industry Segmentation VI Capital Markets for Cannabis Companies • Cannabis is federally illegal in the United States. However, as of VII Top 100 Private Cannabis Companies 2016 the date of this report, 39 states have legalized cannabis in some form for recreational or medicinal use. VIII Industry Risk Factors • The current consumer market for recreational and medicinal IX Glossary of Terms cannabis in the United States is estimated to be more than n Disclosures, Disclaimers, Sources and Use of This Report $40 billion, including both legal and illegal consumption. n Ackrell Capital Team Leaders • We believe that it is a question of when—not if—the federal prohibition on cannabis will end. In analyzing how the end of n Inside Back Cover: The Green Field 2016 prohibition may affect the cannabis industry, we have assumed that prohibition ends by 2020. However, even with federal pro- hibition, the cannabis industry today is large and dynamic. About Ackrell Capital • We estimate that the U.S. cannabis consumer market for legal- ized recreational and medicinal use was $4.4 billion in 2015 Founded in 2003, Ackrell Capital is a leading independent invest- and will grow to $9.5 billion in 2019. Once legalized federally, ment bank focused on emerging growth companies. Ackrell Capi- we estimate this market will grow to $37 billion within 5 years tal’s principals have completed more than 300 corporate finance and $50 billion within 10 years.
    [Show full text]
  • 2021 Meeting Abstractsts
    College on Problems of Drug Dependence (CPDD) Virtual Scientific Meeting, June 21-24, 2021 *All times are listed in the Eastern U.S. Time Zone Monday, June 21, 2021 Late-Breaking Oral Presentations I Initial Results From STAMPOUT: Study of IXT-M200 in Non-Treatment Seeking Persons Who Use Methamphetamine W. Brooks Gentry*1, Lynn Webster2, Keith Ward1, Misty Stevens1 1InterveXion Therapeutics, LLC; University of Arkansas for Medical Sciences, 2PRA Health Sciences Drug Category Stimulants Topic Substance Use Disorder Abstract Detail Human Abstract Category Original Research Aim: IXT-m200 is a high-affinity, anti-methamphetamine (METH) antibody. The aim of this study was to determine the safety, tolerability and pharmacokinetics (PK) of single IV doses of IXT-m200 followed by weekly IV METH challenges in subjects with METH use disorders. The impacts of IXT-m200 on METH PK and on METH effects as measured by drug effects questionnaires (DEQ) were determined. Methods: This was a parallel-group, placebo-controlled, double-blind study in otherwise healthy, non-treatment seeking participants. Subjects were required to discriminate METH (30 mg, IV) from placebo with DEQ to qualify. Those who qualified received single doses of IXT-m200 (6 or 20 mg/kg) or placebo followed by weekly METH challenges for up to 4 weeks. The challenges consisted of METH (30 mg, IV) and placebo, separated by 4 hr. Safety, METH and IXT-m200 PK, and DEQ data were collected for up to 126 days. Results: 56 subjects were included in the pharmacokinetic and safety sets, with 20 receiving the IXT-m200 placebo, 18 receiving 6 mg/kg and 18 receiving 20 mg/kg IXT-m200.
    [Show full text]
  • Marijuana Business Con Erence & Expo®
    Marijuana Business Conerence & Expo® #MJBizCon There’s a better way to navigate the challenges of the cannabis industry... MJardin is uniquely positioned to provide long-term cultivation solutions that increase yields, decrease costs, and add profits to your bottom line. We are cultivators, not consultants. Visit us: MJardin.com Table of Contents Conference Access Icons Your name badge displays icons to indicate your conference access. Use the key below to determine which events you have access Attendee Guidelines .............................................................................................................5 to. To purchase any separately ticketed events, please see a staff member at registration. Who’s Behind This Conference .........................................................................................6 From the Publisher ................................................................................................................7 MJBizCon Through the Years ...........................................................................................8 Conference Sessions OVERFLOW & Expo Halls Wednesday Sessions in Penn & Teller Theater Thank You to Our Sponsors .............................................................................................12 & Expo Halls Agenda-at-a-Glance ............................................................................................................16 W Expo Hall Access WEDNESDAY ONLY Full Agenda & Session Descriptions ............................................................................24
    [Show full text]
  • Alcohol and Vapourized Nicotine Co-Exposure During Adolescence Contribute
    bioRxiv preprint doi: https://doi.org/10.1101/2021.06.23.449629; this version posted June 24, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Alcohol and Vapourized Nicotine Co-Exposure During Adolescence Contribute Differentially to Sex-Specific Behavioural Effects in Adulthood Jessica Ruffolo1,2*, Jude A. Frie1,2*, Hayley H.A. Thorpe1,2, M. Asfandyaar Talhat1, Jibran Y. Khokhar1,2 1 Department of Biomedical Sciences, University of Guelph, Guelph, ON, Canada 2 Collaborative Neurosciences Graduate Program, University of Guelph, Guelph, ON, Canada * Both authors contributed equally to this work Corresponding Author: Jibran Y. Khokhar, Ph.D. [email protected] bioRxiv preprint doi: https://doi.org/10.1101/2021.06.23.449629; this version posted June 24, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. ABSTRACT Introduction: Co-occurrence of e-cigarette use and alcohol consumption during adolescence is frequent. However, little is known about their long-lasting effects when combined. Here, we examined whether adolescent co-exposure to alcohol drinking and vapourized nicotine would impact reward- and cognition-related behaviours in adult male and female rats during adulthood. Methods: Four groups of male and female Sprague Dawley rats (n=8-11/group/sex) received either nicotine (JUUL 5% nicotine pods) or vehicle vapour daily between postnatal days 30-46, while having continuous voluntary access to ethanol and water during this time in a two-bottle preference design.
    [Show full text]
  • The Newface of Big Tobacco
    The new face of Big Tobacco Say NO to Big Marijuana in New Zealand. Don’t Legalise. BRIEFING FOR FAMILIES First Edition February 2019 The new face An Important Resource For Familiesof Big Tobacco Same corporates. WE’VE BEEN SUCKED IN ONCE. Same objectives. Remember Big Tobacco? Tobacco companies lied to New Zealanders Same addiction. and the world for more than a century about the dangers of smoking. New product. They based their market on addiction. They deliberately targeted kids. They even had doctors promote cigarettes as medicine. And today we are paying the price. The conversation is now being dictated by Big Marijuana, who will deny evidence-based science, and will minimise harms by emphasising the economic benefits of large tax revenues. Sound familiar? Ultimately, they’re not in it for the health of your family – Image Source: tobacco.stanford.edu they’re in it to make big money. But people should always come before profits. Because of the lobbying of pro-drug advocates such as the Drug Foundation and the Green Party - and the coalition agreement between Labour, Greens and NZ First made after the last Election - we will be voting on legalising marijuana at the next General Election in 2020 (around September). We know that if marijuana is legalised, a commercial marijuana industry will act just as the tobacco industry acts – irrespective of any ‘regulations’. Today’s highly potent marijuana represents a growing and significant threat to public health and safety, a threat that is amplified by a new marijuana industry intent on profiting from heavy use.
    [Show full text]
  • Effects of Combined THC and Heroin Vapor Inhalation in Rats
    UC San Diego UC San Diego Previously Published Works Title Effects of combined THC and heroin vapor inhalation in rats. Permalink https://escholarship.org/uc/item/7mw911h2 Authors Gutierrez, Arnold Nguyen, Jacques D Creehan, Kevin M et al. Publication Date 2021-06-23 DOI 10.1007/s00213-021-05904-w Peer reviewed eScholarship.org Powered by the California Digital Library University of California Psychopharmacology https://doi.org/10.1007/s00213-021-05904-w ORIGINAL INVESTIGATION Efects of combined THC and heroin vapor inhalation in rats Arnold Gutierrez1,2 · Jacques D. Nguyen1,2 · Kevin M. Creehan1,2 · Mehrak Javadi‑Paydar1 · Yanabel Grant1,2 · Michael A. Tafe1,2 Received: 27 April 2021 / Accepted: 27 May 2021 © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 Abstract Rationale Opioids are efective medications, but they have several key limitations including the development of tolerance, establishment of dependence, diversion for non-medical use, and the development of addiction. Therefore, any drugs which act in an additive or synergistic fashion with opioids to address medical applications have the potential to reduce opioid- related harms. Objectives To determine if heroin and Δ9-tetrahydrocannabinol (THC) interact in an additive or independent manner to alter nociception, body temperature, and spontaneous locomotor activity when inhaled or injected. Methods Groups of female and male rats, implanted with radiotelemetry transmitters, were exposed to vapor generated from heroin (50 mg/mL in propylene glycol vehicle; PG), THC (50 mg/mL), or the combination for assessment of efects on temperature and activity. Thermal nociception was assessed with a warm water tail-withdrawal assay.
    [Show full text]
  • Dispensary Selection Information
    ______________________________________________________________________________________ State of Vermont Department of Public Safety Marijuana Registry [phone] 802-241-5115 45 State Drive [fax] 802-241-5230 Waterbury, Vermont 05671-1300 [email] [email protected] www.medicalmarijuana.vermont.gov Dispensary Selection Information IMPORTANT INFORMATION CONTAINED BELOW WHEN COMPLETING THE FORMS TO REGISTER AS A PATIENT WITH THE VERMONT MARIJUANA REGISTRY (VMR). Materials provided by each dispensary are attached to assist patient applicants designating a dispensary. Registered patients may purchase marijuana, marijuana infused products, seeds, and clones from a registered dispensary. Registered patients who designate a dispensary may purchase marijuana products and cultivate marijuana in a single secure indoor facility. Registered patients who elect to cultivate marijuana in a single secure indoor facility must provide the address and location to the VMR on his or her application. Any updates to the address and/or location of the single secure indoor facility must be submitted in writing via email or mail to the contact information below. Registered patients may only purchase marijuana, marijuana infused products, seeds, and clones from one dispensary and must designate the dispensary of his or her choice on their application. Registered patients may only change dispensaries every 30 days. After 30 days, a registered patient may change his or her designated dispensary by submitting a completed Cardholder Information Notification form and a $25 processing fee. The VMR will issue the registered patient a new registry identification card with a new registry identification number. ALL registered patients and caregivers MUST schedule appointments prior to going to their designated dispensary to obtain marijuana, this includes seed and clones.
    [Show full text]
  • Feds Push Back at Medical Marijuana
    The Cannabis FREE Newspaper of Record www.WestCoastLeaf.com ISSN 1945-221X • Volume 4 No. 2 Summer 2011 FEDS PUSH BACK AT Reaching for new heights MEDICAL MARIJUANA By Kris Hermes, Americans for Safe Access aimed at local and state officials in at least Oakland City Attorney John Russo asked nine different medical marijuana states: Mendocino the Obama Justice Department In February Arizona, California, Colorado, Hawaii, County’s 2011 whether the federal government Maine, Montana, Rhode Island, Vermont tag-permit would approve a city plan to regulate and Washington. large-scale medical marijuana cultivation. At the same time, a blistering wave of process uses As expected, US Attorney Melinda Haag federal raids in several states seems to con- third-party responded with a declarative, “No!” tradict a 2009 federal policy memo on state inspectors for Little did patient advocates realize then medical marijuana laws. that Haag’s letter signaled the launch of a “Every time there’s a raid, or a threat- compliance barrage of similar US Attorney letters ening letter is sent to an elected official, Story inside. hundreds if not thousands of patients are left wondering where they’re going to get Delaware newest their medication,” said Steph Sherer, Executive Director of Americans for Safe Julia Carrera, who medical use state Access. ASA recently launched its ‘Sick and works as a third- Tired’ campaign to bring attention to the party inspector for By Morgan Fox, Marijuana Policy Project continued harassment, discrimination and the Mendocino Delaware Gov. Jack Markell signed SB 17 County medical stigmatization of patients and to call for a marijuana garden into law May 13, making it legal for state comprehensive federal policy.
    [Show full text]